Please complete the inquiry form below. One of our staff will contact you within 1 business day
According to the The Journal of Nuclear Medicine, a new class of radiopharmaceuticals has been developed to non-invasively identify over 30 types of malignant cancerous tumors.The latest Radiotracer uses a modified PET/CT scan (positron emission tomography/computed tomography) to image a large variety of tumors in various stages with high image contrast, paving the way for dozens of potential applications in functional medicine, gene therapies and cancer immunotherapies. The Ga-FAPI radiotracer works by targeting fibroblasts that are associated with various types of cancers and typically contribute up a large quantity of a tumor’s mass. Cancerous fibroblast cells differ from normal (non-cancerous) fibroblasts based on the expression of the FAP proteins (fibroblast activation protein). Fibroblast activated protein inhibitors have been used in several conventional anticancer medications and are now being used with NK cells and in radiopharmaceutical technologies for diagnosis purposes.
Researchers from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) used modified PET/CT scanners to check 80 patients with 31 different kinds of cancers, to see if they could differentiate between metastatic, primary & recurring cancers. Based on the test results scientists found that the difference between metastatic lesions and primary tumors was not significantly different however.
The Ga-FAPI radiotracer was especially accurate in identifying the following types of cancers:
The Ga-FAPI radiotracer was equally as effective as traditional radiology scans while observing the following cancers:
The Ga-FAPI radiotracer was less effective while observing:
The potential benefits of Ga-FAPI radiotracers also include patients not having to fast or recline in specific position during the scans.
The improvements in patient comfort and work-flow for oncologists working in regenerative medicine are also noted as major benefits compared to current technologies.
Zombie cells, also called senescent cells, are non-dividing cells that accumulate in the body due to stress or damage, resisting… Read More
Chimeric antigen receptor-T cell treatment (CAR-T cell therapy) holds immense potential to revolutionize organ transplantation, particularly for patients who struggle… Read More
In the ever-evolving landscape of nutrition science, the discourse around dietary fats has undergone significant transformation. The Regeneration Center is… Read More
New research shows that specific types of brain cells become active after brain injuries and exhibit properties similar to those… Read More
Chemokines, critical components in the immune system, are small proteins that facilitate the migration and positioning of immune cells throughout… Read More
Stem cell research examines everything from gene expression to differentiation capacities to therapeutic potentials. With such diverse data types and… Read More
